JP2021514385A5 - - Google Patents

Info

Publication number
JP2021514385A5
JP2021514385A5 JP2020565534A JP2020565534A JP2021514385A5 JP 2021514385 A5 JP2021514385 A5 JP 2021514385A5 JP 2020565534 A JP2020565534 A JP 2020565534A JP 2020565534 A JP2020565534 A JP 2020565534A JP 2021514385 A5 JP2021514385 A5 JP 2021514385A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
group
halogen
heterocycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020565534A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021514385A (ja
JP7399110B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/053081 external-priority patent/WO2019154956A1/en
Publication of JP2021514385A publication Critical patent/JP2021514385A/ja
Publication of JP2021514385A5 publication Critical patent/JP2021514385A5/ja
Application granted granted Critical
Publication of JP7399110B2 publication Critical patent/JP7399110B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020565534A 2018-02-08 2019-02-08 非縮合チオフェン誘導体及びそれらの使用 Active JP7399110B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18305134 2018-02-08
EP18305134.1 2018-02-08
PCT/EP2019/053081 WO2019154956A1 (en) 2018-02-08 2019-02-08 Non-fused thiophene derivatives and their uses

Publications (3)

Publication Number Publication Date
JP2021514385A JP2021514385A (ja) 2021-06-10
JP2021514385A5 true JP2021514385A5 (cg-RX-API-DMAC7.html) 2022-02-15
JP7399110B2 JP7399110B2 (ja) 2023-12-15

Family

ID=61283124

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020565534A Active JP7399110B2 (ja) 2018-02-08 2019-02-08 非縮合チオフェン誘導体及びそれらの使用

Country Status (15)

Country Link
US (2) US11767316B2 (cg-RX-API-DMAC7.html)
EP (2) EP3749649A1 (cg-RX-API-DMAC7.html)
JP (1) JP7399110B2 (cg-RX-API-DMAC7.html)
KR (2) KR102871188B1 (cg-RX-API-DMAC7.html)
CN (1) CN111936471B (cg-RX-API-DMAC7.html)
AU (1) AU2019219123B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020015743A2 (cg-RX-API-DMAC7.html)
CA (1) CA3087830A1 (cg-RX-API-DMAC7.html)
CO (1) CO2020009106A2 (cg-RX-API-DMAC7.html)
EA (1) EA202091897A1 (cg-RX-API-DMAC7.html)
IL (1) IL275893B2 (cg-RX-API-DMAC7.html)
MX (1) MX2020007917A (cg-RX-API-DMAC7.html)
PH (1) PH12020551175A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202006723SA (cg-RX-API-DMAC7.html)
WO (2) WO2019154953A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA202091897A1 (ru) 2018-02-08 2020-10-27 Энио Фарма Неконденсированные производные тиофена и их применение
MX2020007918A (es) 2018-02-08 2020-12-03 Enyo Pharma Derivados fusionados de tiofeno y sus usos.
CN114555577A (zh) * 2019-10-17 2022-05-27 埃尼奥制药公司 用于治疗门静脉炎症和纤维化的噻吩衍生物
PH12022551379A1 (en) 2019-12-06 2023-05-03 Vertex Pharma Substituted tetrahydrofurans as modulators of sodium channels
TWI775313B (zh) 2020-02-18 2022-08-21 美商基利科學股份有限公司 抗病毒化合物
KR20250133471A (ko) 2020-02-18 2025-09-05 길리애드 사이언시즈, 인코포레이티드 항바이러스 화합물
TWI794742B (zh) 2020-02-18 2023-03-01 美商基利科學股份有限公司 抗病毒化合物
JP2023537271A (ja) * 2020-07-24 2023-08-31 イニファーム,インク. チオフェンhsd17b13阻害剤とその使用
IL299972A (en) 2020-08-05 2023-03-01 Enyo Pharma Thiophane compounds for use in the treatment of renal fibrosis
CN116670118B (zh) 2020-11-13 2026-02-06 伊尼制药公司 二氯苯酚hsd17b13抑制剂及其用途
CN112851633B (zh) * 2021-01-19 2021-12-07 上海应用技术大学 一种2-氨基噻吩类神经氨酸酶抑制剂及其制备方法与应用
US12617772B2 (en) 2021-04-05 2026-05-05 Inipharm, Inc. Hydroxypyridine HSD17B13 inhibitors and uses thereof
AU2022256476B2 (en) 2021-04-16 2025-06-05 Gilead Sciences, Inc. Methods of preparing carbanucleosides using amides
SI4347031T1 (sl) 2021-06-04 2026-01-30 Vertex Pharmaceuticals Incorporated N-(hidroksialkil (hetero)aril) tetrahidrofuran karboksamidi kot modulatorji natrijevih kanalčkov
CA3228162A1 (en) 2021-08-18 2023-02-23 Gilead Sciences, Inc. Phospholipid compounds and methods of making and using the same
EP4578939A4 (en) * 2022-08-17 2026-04-22 Guanghao Peng MYCOBACTERIUM SP. BASED ON VARIOUS CARBON-NITROGEN METABOLIC PATHWAYS, METHOD FOR ISOLATING IT AND ITS USE

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9924092D0 (en) 1999-10-13 1999-12-15 Zeneca Ltd Pyrimidine derivatives
US20050085531A1 (en) * 2003-10-03 2005-04-21 Hodge Carl N. Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
DE10359791A1 (de) * 2003-12-19 2005-07-21 Bayer Healthcare Ag Substituierte Thiophene
RU2465272C2 (ru) * 2007-09-10 2012-10-27 КалсиМедика, Инк. Соединения, моделирующие внутриклеточный кальций
WO2009076454A2 (en) * 2007-12-12 2009-06-18 Calcimedica, Inc. Compounds that modulate intracellular calcium
CA2734500A1 (en) * 2008-08-27 2010-03-11 Calcimedica Inc. Compounds that modulate intracellular calcium
US20110319416A1 (en) 2009-01-28 2011-12-29 Emory University Subunit Selective NMDA Receptor Antagonists For The Treatment Of Neurological Conditions
WO2011097607A1 (en) 2010-02-08 2011-08-11 Southern Research Institute Anti-viral treatment and assay to screen for anti-viral agent
US20150126519A1 (en) * 2012-03-20 2015-05-07 Fred Hutchinson Cancer Research Center Antibiotic compounds and compositions, and methods for identification thereof
EP2679591A1 (en) 2012-06-29 2014-01-01 Poxel Thienopyridone derivatives useful as activators of AMPK
WO2015187827A1 (en) 2014-06-03 2015-12-10 The Trustees Of The University Of Pennsylvania Novel effective antiviral compounds and methods using same
WO2016008411A1 (en) 2014-07-18 2016-01-21 Beigene, Ltd. 5-amino-4-carbamoyl-pyrazole compounds as selective and irreversible t790m over wt-egfr kinase inhibitors and use thereof
KR20190098204A (ko) 2016-12-29 2019-08-21 엔요 파마 항바이러스제로서의 티오펜 유도체
EA202091897A1 (ru) 2018-02-08 2020-10-27 Энио Фарма Неконденсированные производные тиофена и их применение
EP3749292A1 (en) 2018-02-08 2020-12-16 ENYO Pharma Use of modulators of neet proteins for the treatment of infection
MX2020007918A (es) 2018-02-08 2020-12-03 Enyo Pharma Derivados fusionados de tiofeno y sus usos.

Similar Documents

Publication Publication Date Title
JP2021514384A5 (cg-RX-API-DMAC7.html)
IL275893B1 (en) Non-fused thiophene derivatives and their uses
JP2022544714A5 (cg-RX-API-DMAC7.html)
TWI874490B (zh) 三苯化合物之新穎鹽類
JP2023534983A5 (cg-RX-API-DMAC7.html)
JP2023538408A5 (cg-RX-API-DMAC7.html)
JP2020189882A (ja) Mekインヒビターおよびその使用方法
WO2022230912A1 (ja) 置換トリアジン化合物
JP2011528370A5 (cg-RX-API-DMAC7.html)
JP2021531234A5 (cg-RX-API-DMAC7.html)
RU2011105422A (ru) Дейтерированные бензилбензольные производные и способы применения
JP2006516622A5 (cg-RX-API-DMAC7.html)
TWI668217B (zh) 二氫嘧啶類化合物及其在藥物中的應用
US20160166548A1 (en) ISOXAZOLE HYDROXAMIC ACID COMPOUNDS AS LpxC INHIBITORS
JP2022548250A5 (cg-RX-API-DMAC7.html)
JP2024541920A5 (cg-RX-API-DMAC7.html)
JP2022543666A5 (cg-RX-API-DMAC7.html)
JP2024513227A5 (cg-RX-API-DMAC7.html)
JP2022519131A5 (cg-RX-API-DMAC7.html)
JP2025503502A5 (cg-RX-API-DMAC7.html)
JP2019502659A5 (cg-RX-API-DMAC7.html)
WO2025146112A1 (en) Gspt1 degrading compounds and compositions and uses thereof
SG176865A1 (en) Novel gpr 119 agonists
JP2019501123A5 (cg-RX-API-DMAC7.html)
JP2024506530A5 (cg-RX-API-DMAC7.html)